|
|
|
| Comparison of Efficacy of Continuous Blood Purification and Ordinary Hemodialysis on Patients with Uremia |
| LI Gang, GUO Hao |
| The First People's Hospital of Tianmen City, Hubei Tianmen 431700, China |
|
|
|
|
Abstract Objective: To observe the effect of continuous blood purification and ordinary hemodialysis on patients with uremia, and to conduct a comparative study. Methods: 180 cases of uremia patients treated in our hospital were selected and randomly divided into control group and observation group, 90 cases in each group. The control group underwent conventional dialysis treatment, with each dialysis of 4 hours, 3 times a week, and the intervention lasted 3 months. The observation group underwent a continuous blood purification dialysis treatment, 3 times during the day and 1 time at night in a day, and the intervention lasted 3 months. The clinical efficacy and serum HMG-1 and TNF-α levels in the two groups were observed. Results: The observation group had 85 effective cases, accounting for 94.4%; the control group had an effective rate of 76.6% (P<0.05). After treatment, the renal function indexes of the two groups decreased; difference before and after treatment in the observation group was greater than that in the control group (P<0.05). After treatment, difference before and after treatment of HMG-1 and TNF-α in the observation group was significantly greater than that in the control group (P<0.05). After treatment, the levels of LA, CRP, and PCT in the two groups decreased compared with those before treatment. After treatment, difference before and after treatment of LA, CRP, and PCT in the treatment group was greater than that in the control group (P<0.05). The outcome of the patients was followed up for 28 days. As a result, there were 10 deaths in the control group, with a case fatality rate of 11.1%; 2 cases in the treatment group died, with a case fatality rate of 2.22% (P<0.05). Conclusion: Continuous blood purification is effective in treating uremia and can effectively reduce the levels of HMG-1 and TNF-α in serum, at the same time improve the survival rate of patients.
|
|
|
|
|
|
[1] 常文静,次仁央金.血液透析与高通量血液透析对尿毒症合并高磷血症患者血清PTH机体营养状况的影响[J].河北医学,2019,25(9):1556~1559.
[2] 黄凤梅,艾凌艳,谢小街,等.连续性血液净化联合腹膜透析治疗高危尿毒症患者的研究及临床应用[J].透析与人工器官,2020,31(2):7~9,12.
[3] 邱宏.几种血液净化方式治疗尿毒症患者药物性脑病疗效的比较研究[J].世界最新医学信息文摘,2019,19(4):130~133.
[4] 张金凤.连续性血液净化治疗尿毒症难治性高血压的效果[J].中西医结合心血管病电子杂志,2019,7(5):64.
[5] 何文梅.1例产后溶血性尿毒症的护理[J].按摩与康复医学,2019,10(3):81~82.
[6] 张坚.尿毒症难治性高血压患者采用连续性血液净化治疗的临床分析[J].国际医药卫生导报,2018,24(18):2794~2796.
[7] 齐云争.连续性血液净化治疗尿毒症患者的效果[J].医疗装备,2020,33(10):13~14.
[8] 穆立芹,王静,李明明,等.探讨尿毒症血液透析患者透析前后免疫指标及IL-6、CRP、IL-8、TNF-α的变化[J].现代免疫学,2017,37(6):489~493. |
|
|
|
2021, Vol. 27 
